Prof. Dr. S.P. Singh

Prof. Dr. S.P. Singh

Professor And HOD

Prof. Dr S.P. Singh

Professor And HOD
Email: spsingh.cuttack@gmail.com
Permanent Address: Plot # 1362/B, Sector 6, Abhinava Bidanasi, Cuttack 753014, Odisha, India
Correspondence Address: Plot # 1362/B, Sector 6, Abhinava Bidanasi, Cuttack 753014, Odisha, India.
Course Name Name of PG Degree Area of Specialization/ Specialty Year of Qualifying degree Name of University / Institute
MBBS 1980 Utkal University
PG Degree MD General medicine 1985 Utkal University
Super Specialization DM Gastroenterology 1988 Madras University
  1. Singh SP, Anirvan P, Reddy KR, Acharya SK, Goh K-L, et al. Non-alcoholic Fatty Liver Disease: Not Time for an Obituary Just Yet! J Hepatol. 2020. Published Online December 16, 2020DOI:https://doi.org/10.1016/j.jhep.2020.10.015
  2. Anirvan P, Sonali Narain S, Hajizadeh N, Aloor FZ, Singh SP, Satapathy SK.Cytokine-induced liver injury in coronavirus disease-2019 (COVID-19): untangling the knots. Eur J Gastroenterol Hepatol Accepted. DOI: 10.1097/MEG.0000000000002034
  3. Anirvan P, Bharali P, Gogoi M, Thuluvath PJ, Singh SP, Satapathy SK. Liver injury in COVID-19: The hepatic aspect of the respiratory syndrome — what we know so far. World JHepatol 2020; 12(12): . URL: https://www.wjgnet.com/1948-5182/full/v12/i12/0.htm DOI: https://dx.doi.org/10.4254/wjh.v12.i12.0000
  4. Khatua CR, Sahu SK, Meher D, Nath G,Singh SP. Acute kidney injury in hospitalized cirrhotic patients: Riskfactors, type of kidney injury, and survival. JGH Open 2020 doi:10.1002/jgh3.12467
  5. Nayak A, Roy AD, Rout N, Singh SP, Bhattacharyya A, Roychowdhury A. HIF1α-dependent upregulation of ATAD2 promotes proliferation and migration of stomach cancer cells in response to hypoxia. Biochem Biophys Res Commun. 2020 Jan 17. pii: S0006-291X(20)30097-8. doi: 10.1016/j.bbrc.2019.12.130. [Epub ahead of print].
  6. Kumar A, Acharya SK, Singh SP et al. 2019 Update of Indian National Association for Study of the Liver Consensus on Prevention, Diagnosis, and Management of Hepatocellular Carcinoma in India: The Puri II Recommendations. J Clin Exp Hepatol 2020;10,:43-80.
  7. Singh SP, Barik RK. NonInvasive Biomarkers in Nonalcoholic Fatty Liver Disease: Are We There Yet? J Clin Exp Hepatol 2020;10:88–98.
  8. Nath P, Panigrahi MK, Sahu MK, Narayan J, Sahoo RK, Patra AA, Jena S, Patnaik AK, Jena A, Singh SP. Effect of exercise on NAFLD and its risk factors: Comparison of moderate versus low intensity exercise. J Clin Transl Hepatol. 2020;8(2):1-7.
  9. Anand AC, Nandi B, Acharya SK, Arora A, Babu S, Batra Y, Chawla YK, Chowdhury A, Chaoudhuri A, Eapen EC, Devarbhavi H, Dhiman R, Datta Gupta S, Duseja A, Jothimani D, Kapoor D, Kar P, Khuroo MS, Kumar A, Madan K, Mallick B, Maiwal R, Mohan N, Nagral A, Nath P, Panigrahi sC, Pawar A, Philips CA, Prahraj D, Puri P, Rastogi A, Saraswat VA, Saigal S, Shalimar, Shukla A, Singh SP, Verghese T, Wadhawan M, The INASL Task-Force on Acute Liver Failure.INASL Consensus Statement on Acute Liver Failure (Part-1): Epidemiology, Pathogenesis, Presentation and Prognosis. J Clin Exp Hepatol 2020 https://doi.org/10.1016/j.jceh.2020.04.012.
  10. Anand AC, Nandi B, Acharya SK, Arora A, Babu S, Batra Y, Chawla YK,Chowdhury A, Chaoudhuri A, Chundamannil Eapen E, Devarbhavi H, Dhiman R, Datta Gupta S, Duseja A, Jothimani D, Kapoor D, Kar P, Khuroo MS, Kumar A, Madan K, Mallick B, Maiwal R, Mohan N,Nagral A, Nath P, Panigrahi SC, Pawar A, Philips CA, Prahraj D, Puri P, Rastogi A, Saraswat VA, Saigal S, Shalimar, Shukla A, Singh SP, Verghese T, Wadhawan M, The INASL Task-Force on Acute Liver Failure. INASL Consensus Statement on Acute Liver Failure (Part-2): Management of Acute Liver Failure. J Clin Exp Hepatol 2020 https://doi.org/10.1016/j.jceh.20
  11. Mishra D, Dash KR, Khatua CR, Panigrahi S, Parida PK, Behera SK, Barik RK, Pradhan S, Sahu SK, Thakur B, Singh SP. A Study On The Temporal Trends in the Etiology of Cirrhosis of  Liver In Coastal Eastern Odisha. Euroasian J Hepatogastroenterol. 2020;10(1):1–6.
  12. Sood A, Ahuja V, Midha V, Sinha SK, Pai CG, Kedia S, Mehta V, Bopanna S, Abraham P, Banerjee R, Bhatia S, Chakravartty K, Dadhich S, Desai D, Dwivedi M, Goswami B, Kaur K, Khosla R, Kumar A, Mahajan R, Misra SP, Peddi K, Singh SP, Singh A. Colitis and Crohn’s Foundation (India) consensus statements on use of 5-aminosalicylic acid in inflammatory bowel disease. Intest Res. 2020 Jul 13. doi: 10.5217/ir.2019.09176. Online ahead of print.
  13. Anirvan P, Meher D, Singh SP. Artificial Intelligence in Gastrointestinal Endoscopy in a Resource-constrained Setting: A Reality Check. Euroasian J Hepatogastroenterol [2020]: 10.5005/jp-journals-10018-1322
  14. Wong F, Piano S, Singh V, Bartoletti M, Maiwall R, Alessandria C, Fernandez J, Soares EC, Kim DJ, Kim SE, Marino M, Vorobioff J, Baria RCR, Merli M, Elkrief L. Vargas V, Krag A, Singh SP, et al. Clinical Features and Evolution of Bacterial Infection-Related Acute-on-Chronic Liver Failure : a Global Perspective. J Hepatol. 2020 Aug 8:S0168-8278(20)30533-X. doi: 10.1016/j.jhep.2020.07.046. Epub ahead of print. PMID: 32781201.
  15. Devarbhavi H, Joseph T, Kumar NS, Rathi C, Thomas V, Singh SP, Sawant P, Goel A, Eapen CE, Rai P, Arora A. et al. The Indian Network of Drug-Induced Liver Injury: Etiology, Clinical Features, Outcome and Prognostic Markers in 1288 Patients. J Clin Exp Hepatol. 2020.https://doi.org/10.1016/j.jceh.2020.11.002
  16. Nutrition in Liver Diseases: Consensus statement of the Indian National Association for Study of the Liver (INASL). J Clin Exp Hepatol 2020. [In Press].
  17. INASL-ISN Joint Position Statements on Management of Patients with Simultaneous Liver and Kidney Disease. J Clin Exp Hepatol. 2020.https://doi.org/10.1016/j.jceh.2020.09.005
  18. Meher D, Gogoi M, Bharali P, Anirvan P, Singh SP. Artificial Intelligence in Small Bowel Endoscopy: Current perspectives and future directions. J Digest Endosc2020[In Press].  DOI https://doi.org/ 10.1055/s-0040-1717824
  19. Satiya J, Snyder HS, Singh SP, Satapathy SK. Narrative Review of Current and Emerging Pharmacological Therapies for Nonalcoholic Steatohepatitis. Transl Gastroenterol Hepatol 2020[In Press].  http://dx.doi.org/10.21037/tgh-20-247
  20. Kumar A, Acharya SK, Singh SP, Arora A, Dhiman RK, Aggarwal R, et al. 2019 Update of Indian National Association for Study of the Liver (INASL) Consensus on Prevention, Diagnosis and Management of Hepatocellular Carcinoma in India: The Puri II Recommendations. J Clin Exp Hepatol. 2019 doi: DOI: 10.1016/j.jceh.2019.09.007Epub 2019 Sept23. Review.
  21. Singh SP, Barik RK. Non-invasive biomarkers in Non-alcoholic Fatty Liver Disease – are we there yet?.J Clin Exp Hepatol. 2019 doi: DOI: 10.1016/j.jceh.2019.09.006Epub 2019 Sept21. Review.
  22. Khatua CR, Sahu SK, Barik RK, Pradhan S, Panigrahi S, Mishra D, Singh SP.Validation of International Club of Ascites subclassification of stage 1 acute kidney injury in chronic liver disease.JGH Open. 2019 Feb 27;3(4):290-294. doi: 10.1002/jgh3.12152. eCollection 2019 Aug
  23. Kedia S, Sharma R, Makharia G, Ahuja V, Desai D, Kandasamy D, Eapen A, Ganesan K, Ghoshal UC, Kalra N, Karthikeyan R, Madhusudhan KS, Philip M, Puri A, Puri S, Sinha SK, Banerjee R, Bhatia S, Bhat N, Dadhich S, Dhali G K, Goswami B D, Issar S K, Jayanthi V, Misra S P, Nijhawan S, Puri P, Sarkar A, Singh S P, Srivastava A, Abraham P, Ramakrishna B S. Indian guidelines on imaging of the small intestine in Crohn’s disease: A joint Indian Society of Gastroenterology and Indian Radiology and Imaging Association consensus statement. Indian J Radiol Imaging 2019;29:111-32
  24. Arora A, Kumar A, Anand AC, Puri P, Dhiman RK, Acharya SK, Aggarwal K, Aggarwal N, Aggarwal R, Chawla YK, Dixit VK, Duseja A, Eapen CE, Goswami B, Gujral K, Gupta A, Jindal A, Kar P, Kumari K, Madan K, Malhotra J, Malhotra N, Pandey G, Pandey U, Puri RD, Rai RR, Rao PN, Sarin SK, Sharma A, Sharma P, Shenoy KT, Singh KR, Singh SP, Suri V, Trehanpati N, Wadhawan M. Indian National Association for the Study of the Liver-Federation of Obstetric and Gynaecological Societies of India Position Statement on Management of Liver Diseases in Pregnancy. J Clin Exp Hepatol. 2019 May-Jun;9(3):383-406. doi: 10.1016/j.jceh.2019.02.007. Epub 2019 Mar 6. Review.
  25. Sood A, Ahuja V, Kedia S, Midha V, Mahajan R, Mehta V, Sudhakar R, Singh A, Kumar A, Puri AS, Tantry BV, Thapa BR, Goswami B, Behera BN, Ye BD, Bansal D, Desai D, Pai G, Yattoo GN, Makharia G, Wijewantha HS, Venkataraman J, Shenoy KT, Dwivedi M, Sahu MK, Bajaj M, Abdullah M, Singh N, Singh N, Abraham P, Khosla R, Tandon R, Misra SP, Nijhawan S, Sinha SK, Bopana S, Krishnaswamy S, Joshi S, Singh SP, Bhatia S, Gupta S, Bhatia S, Ghoshal UC. Diet and inflammatory bowel disease: The Asian Working Group guidelines. Indian J Gastroenterol. 2019 Jun;38(3):220-246. doi: 10.1007/s12664-019-00976-1. Epub 2019 Jul 27.
  26. Meher D, Khatua CR, Singh SP. Concerns regarding the AARC Study on Corticosteroid therapy for Autoimmune Hepatitis flare causing ACLF. Hepatology. 2019 May 23. doi: 10.1002/hep.30787.
  27. Parida PK, Mishra D, Pati GK, Nath P, Dash KR, Behera SK, Parida S, Khatua CR, Panigrahi S, Mahapatra A, Khuntia HK, Singh SP. A prospective study on incidence, risk factors, and validation of a risk score for post-infection irritable bowel syndrome in coastal eastern India. Indian J Gastroenterol. 2019 Apr;38(2):134-142. doi: 10.1007/s12664-019-00943-w. Epub 2019 Apr 4.
  28. Singh SP, Panigrahi S, Mishra D, Khatua CR. Alcohol-associated liver disease, not hepatitis B, is the major cause of cirrhosis in Asia. J Hepatol. 2019 May;70(5):1031-1032. doi: 10.1016/j.jhep.2019.01.003. Epub 2019 Feb 16. No abstract available.
  29. Khatua CR, Panigrahi S, Mishra D, Pradhan S, Sahu SK, Barik RK, Parida PK, Behera S, Parida S, Singh SP. Acute Kidney Injury at Admission Is a Better Predictor of Mortality than Its Persistence at 48 h in Patients with Acute-on-chronic Liver Failure. J Clin Transl Hepatol. 2018 Dec 28;6(4):396-401. doi: 10.14218/JCTH.2018.00035. Epub 2018 Dec 3.
  30. Ghoshal UC, Sachdeva S, Pratap N, Verma A, Karyampudi A, Misra A, Abraham P, Bhatia SJ, Bhat N, Chandra A, Chakravartty K, Chaudhuri S, Chandrasekar TS, Gupta A, Goenka M, Goyal O, Makharia G, Mohan Prasad VG, Anupama NK, Paliwal M, Ramakrishna BS, Reddy DN, Ray G, Shukla A, Sainani R, Sadasivan S, Singh SP, Upadhyay R, Venkataraman J. Indian consensus on chronic constipation in adults: A joint position statement of the Indian Motility and Functional Diseases Association and the Indian Society of Gastroenterology.Indian J Gastroenterol. 2018 Nov;37(6):526-544. doi: 10.1007/s12664-018-0894-1. Epub 2019 Jan 8.
  31. Arora A, Anand AC, Kumar A, Singh SP, Aggarwal R, Dhiman RK, Aggarwal S, Alam S, Bhaumik P, Dixit VK, Goel A, Goswami B, Kumar A, Kumar M, Madan K, Murugan N, Nagral A, Puri AS, Rao PN, Saraf N, Saraswat VA, Sehgal S, Sharma P, Shenoy KT, Wadhawan M; Members of the INASL taskforce on Hepatitis B. INASL Guidelines on Management of Hepatitis B Virus Infection in Patients receiving Chemotherapy, Biologicals, Immunosupressants, or Corticosteroids. J Clin Exp Hepatol. 2018 Dec;8(4):403-431. doi: 10.1016/j.jceh.2018.06.010. Epub 2018 Jun 26.
  32. Piano S, Singh V, Caraceni P, Maiwall R, Alessandria C, Fernandez J, Soares EC, Kim DJ, Kim SE, Marino M, Vorobioff J, Barea RCR, Merli M, Elkrief L, Vargas V, Krag A, Singh SP, Lesmana LA, Toledo C, Marciano S, Verhelst X, Wong F, Intagliata N, Rabinowich L, Colombato L, Kim SG, Gerbes A, Durand F, Roblero JP, Bhamidimarri KR, Boyer TD, Maevskaya M, Fassio E, Kim HS, Hwang JS, Gines P, Gadano A, Sarin SK, Angeli P; International Club of Ascites Global Study Group. Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide.Gastroenterology. 2019 Apr;156(5):1368-1380.
  33. Kokate SB, Dixit P, Das L, Rath S, Roy AD, Poirah I, Chakraborty D, Rout N, Singh SP, Bhattacharyya A. Acetylation-mediated Siah2 stabilization enhances PHD3 degradation in Helicobacter pylori-infected gastric epithelial cancer cells. FASEB J. 2018 Apr 24:fj201701344RRR. doi: 10.1096/fj.201701344RRR. [Epub ahead of print]
  34. Asthana M, Sahu SK, Kumar A, Mohanty S, Chakrabarti S, Das P, Chattopadhya NR, Chatterjee K, Singh SP, Rajasubramaniam S, Choudhuri T. Role of Interleukin 28B polymorphisms in response to Interferon based therapy for hepatitis C virus clearance. Curr Drug Metab. 2018 Jan 28. doi: 10.2174/1389200219666180129115359. [Epub ahead of print]
  35. Kedia S, Sharma R, Makharia GK, Ahuja V, Desai D, Kandasamy D, Eapen A, Ganesan K, Ghoshal UC, Kalra N, Karthikeyan D, Madhusudhan KS, Philip M, Puri AS, Puri S, Sinha SK, Banerjee R, Bhatia S, Bhat N, Dadhich S, Dhali GK, Goswami BD, Issar SK, Jayanthi V, Misra SP, Nijhawan S, Puri P, Sarkar A, Singh SP, Srivastava A, Abraham P, Ramakrishna BS; for Indian Society of Gastroenterology Task Force on Inflammatory Bowel Disease. Imaging of the small intestine in Crohn’s disease: Joint position statement of the Indian Society of Gastroenterology and Indian Radiological and Imaging Association. Indian J Gastroenterol. 2018 Jan 6. doi: 10.1007/s12664-017-0804-y. [Epub ahead of print].
  36. Arora A, Singh SP, Kumar A, Saraswat VA, Aggarwal R, Bangar M, Bhaumik P, Devarbhavi H, Dhiman RK, Dixit VK, Goel A, Goswami B, Kapoor D, Madan K, Narayan J, Nijhawan S, Pandey G, Rai RR, Sahu MK, Saraf N, Shalimar, Shenoy T, Thomas V, Wadhawan M, INASL Hepatitis B Taskforce. INASL Position Statements on Prevention, Diagnosis and Management of Hepatitis B Virus Infection in India: The Andaman Statements. J Clin Exp Hepatol. 2017 In Press. doi: 10.1016/j.jceh.2017.12.001. Epub 2017 Dec 16.
  37. Pattnaik K, Bhuyan P, Singh A, Singh SP, Nath P, Kar S, Misra B, Rath J. Biopsy Proven Fibrosis in Non-Alcoholic Fatty Liver Disease: An Analysis of Risk Factors. J Clin Exp Hepatol. 2018 Dec;8(4):367-374. doi: 10.1016/j.jceh.2017.12.008. Epub 2018 Jan 8.
  38. Nath P, Singh SP. Nonalcoholic Fatty Liver Disease: Time to Take the Bull by the Horns. Euroasian J Hepatogastroenterol. 2018 Jan-Jun;8(1):47-51. doi: 10.5005/jp-journals-10018-1257. Epub 2018 May 1
  39. Das D, Sengupta I, Sarkar N, Pal A, Saha D, Bandopadhyay M, Das C, Narayan J, Singh SP, Chakrabarti S, Chakravarty R. Anti-hepatitis B virus (HBV) response of imiquimod based toll like receptor 7 ligand in hbv-positive human hepatocelluar carcinoma cell line. BMC Infect Dis. 2017 Jan 14;17(1):76. doi: 10.1186/s12879-017-2189-z.
  40. Das L, Kokate SB, Dixit P, Rath S, Rout N, Singh SP, Crowe SE, Bhattacharyya A.Membrane-bound β-catenin degradation is enhanced by ETS2-mediated Siah1 induction in Helicobacter pylori-infected gastric cancer cells. Oncogenesis. 2017 May 8;6(5):e327. doi: 10.1038/oncsis.2017.26..
  41. Rath S, Das L, Kokate SB, Ghosh N, Dixit P, Rout N, Singh SP, Chattopadhyay S, Ashktorab H, Smoot DT, Swamy MM, Kundu TK, Crowe SE, Bhattacharyya A. Inhibition of histone/lysine acetyltransferase activity kills CoCl2-treated and hypoxia-exposed gastric cancer cells and reduces their invasiveness. Int J Biochem Cell Biol. 2017 Jan;82:28-40. doi: 10.1016/j.biocel.2016.11.014. Epub 2016 Nov 23.
  42. Singh A, Nath P, Parida S, Narayan J, Padhi PK, Pati GK, Parida PK, Meher C, Agrawal O, Singh SP. Simple anthropometric indices are useful for predicting Non-alcoholic fatty liver disease [NAFLD] in Asian Indians. J Clin Exp Hepatol.2017 [In Press]. DOI: http://dx.doi.org/10.1016/j.jceh.2017.05.005
  43. Duseja A, Singh SP. Towards a better definition of Acute-on-Chronic Liver Failure. J Clin Exp Hepatol.2017 [In Press]. DOI: http://dx.doi.org/10.1016/j.jceh.2017.05.002
  44. Swain M, Mohanty R, Kar SK, Singh SP, Rout N. An audit of Endoscopic Rapid Urease Test [RUT] and treatment for Helicobacter Pylori infection in Clinical Practice. Journal of Pure and Applied Microbiology 2017;11[2] [In Press].
  45. Narayan J, Nath P, Singh A, Padhi PK, Parida PK, Pati GK, Singh SP. Leech infestation presenting as severe rectal bleeding. J Dig Endosc 2017;8 [In Press].
  46. Rath S, Das L, Kokate SB, Ghosh N, Dixit P, Rout N, Singh SP, Chattopadhyay S, Ashktorab H, Smoot DT, Swamy MM, Kundu TK, Crowe SE, Bhattacharyya A. Inhibition of histone/lysine acetyltransferase activity killsCoCl2-treated and hypoxia-exposed gastric cancer cells and reducestheir invasiveness. Int J Biochem Cell Biol. 2016 Nov 23. pii: S1357-2725(16)30354-5. doi: 10.1016/j.biocel.2016.11.014. [Epub ahead of print]
  47. Paliwal S, Bhaskar S, Reddy DN, Rao GV, Thomas V, Singh SP, Chandak GR. Association Analysis of PRSS1-PRSS2 and CLDN2-MORC4 Variants in Nonalcoholic Chronic Pancreatitis Using Tropical Calcific Pancreatitis as Model. Pancreas 2016 Jan 18. [Epub ahead of print].
  48. Rath S, Anand A, Ghosh N, Das L, Kokate SB, Dixit P, Majhi S, Rout N, Singh SP, Bhattacharyya A. Cobalt chloride-mediated protein kinase Cα (PKCα) phosphorylation induces hypoxia-inducible factor 1α (HIF1α) in the nucleus of gastric cancer cell. Biochem Biophys Res Commun 2016 Feb 26;471(1):205-12. doi: 10.1016/j.bbrc.2016.01.140. Epub 2016 Jan 28.
  49. Thorhauge KH, Lindvig KP, Laleman W, Angeli P, Singh SP, Krag A. Lack of consensus for usage of β-blockers in end-stage liver disease. Gut 2016 Mar 1. pii: gutjnl-2016-311573. doi: 10.1136/gutjnl-2016-311573.
  50. Singh SP, Kar SK. The Lean NASH Conundrum. J Diabetes Metab 2016;7(642):2.
  51. Shalimar, Saraswat V, Singh S, Duseja A, Shukla A, Eapen CE, Kumar D, Pandey G, Venkataraman J, Narayanswami K, Puri P, Dhiman RK, Thareja S, Nijhawan S, Bhatia S, Zachariah U, Sonika U, Thomas V, Acharya SK. Acute on chronic liver failure in India: the INASL Consortium experience. JGastroenterol Hepatol. 2016 Mar 16. doi: 10.1111/jgh.13340. [Epub ahead of print].
  52. Sahu SK, Chakrabarti S, Roy SD, Baishya N, Reddy RR, Suklabaidya S, Kumar A, Mohanty S, Maji S, Suryanwanshi A, Rajasubramaniam S, Asthana M, Panda AK, Singh SP, Ganguly S, Shaw OP, Bichhwalia AK, Sahoo PK, Chattopadhyay NR, Chatterjee K, Kundu CN, Das AK, Kannan R, Zorenpuii, Zomawia E, Sema SA, Singh YI, Ghosh SK, Sharma K, Das BS, Choudhuri T. Association of p53 codon72 Arg>Pro polymorphism with susceptibility to nasopharyngeal carcinoma: Evidence from a case-control study and meta-analysis. Oncogenesis2016 May 9;5:e225. doi: 10.1038/oncsis.2016.31.
  53. Das L, Kokate SB, Rath S, Rout N, Singh SP, Crowe SE, Mukhopadhyay AK, Bhattacharyya A. ETS2 and Twist1 promote invasiveness of Helicobacter pylori-infected gastric cancer cells by inducing Siah2. Biochem J. 2016 Apr 5. pii: BCJ20160187.
  54. Shalimar, Saraswat, V, Singh, S, Duseja, A, Shukla, A, Eapen, CE, Kumar, D, Pandey, G, Venkataraman, J, Narayanswami, K, Puri, P, Dhiman, RK, Thareja, S, Nijhawan, S, Bhatia, S, Zachariah, U, Sonika, U, Thomas, V, Acharya, SK. Acute on chronic liver failure in India: the INASL Consortium experience. Journal of Gastroenterology and Hepatology, doi: 10.1111/jgh.13340.
  55. Singh SP, Padhi PK, Narayan J, Singh A, Pati GK, Nath P, Parida PK, Mishra S. Socioeconomic impact of alcohol in patients with alcoholic liver disease in eastern India. Ind J Gastroenterol 2016; DOI 10.1007/s12664-016-0699-z
  56. Shah SR, Rao PN, Sarin SK, Chowdhury A, Bhatia S, Dharamsi R, Goswami BD, Kapoor D, Luaia R, Mehta R, Mukewar S, Prasad VG, Rai RR, Saigal S, Singh D, Trehanpati N, Chen S, Gaggar A, Knox SJ, Subramanian GM, Singh SP, Sood A, Varghese J, Venugopal RV. Chronic hepatitis C virus infection in India: Regional demographics and distribution of viral genotypes. Indian JGastroenterol. 2016 Nov 15. [Epub ahead of print]
  57. Puri P, Saraswat VA, Dhiman RK, Anand AC, Acharya SK, Singh SP, Chawla YK, Amarapurkar DN, Kumar A, Arora A, Dixit VK, Koshy A, Sood A, Duseja A, Kapoor D, Madan K, Srivastava A, Kumar A, Wadhawan M, Goel A, Verma A, Shalimar, Pandey G, Malik R, Agrawal S. Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection: Update 2016. J Clin Exp Hepatol.2016 Jun;6(2):119-45. doi: 10.1016/j.jceh.2016.07.001. Review.
  58. Pati GK, Singh A, Misra B, Misra D, Das HS, Panda C, Singh SP. Acute-on-Chronic Liver Failure (ACLF) in Coastal Eastern India: “A Single-Center Experience”. J Clin Exp Hepatol. 2016 Mar;6(1):26-32. doi: 10.1016/j.jceh.2015.08.002.
  59. Rath MM, Panigrahi MK, Pattnaik K, Bhuyan P, Kar SK, Misra B, Misra D, Meher C, Agrawal O, Rath J, Singh SP. Histological Evaluation of Non-alcoholic Fatty Liver Disease and Its Correlation with Different Noninvasive Scoring Systems with Special Reference to Fibrosis. J Clin Exp Hepatol. 2016.[In Press] doi:10.1016/j.jceh.2016.08.006.
  60. Swain M, Nath P, Parida PK, Narayan J, Padhi PK, Pati GK, Singh A, Misra B, Misra D, Kar SK, Panigrahi MK, Meher C, Agrawal O, Rout N, Pattnaik K, Bhuyan P, Mishra PK, Singh SP.Biochemical Profile of Nonalcoholic Fatty Liver Disease Patients in Eastern India with Histopathological Correlation. Ind J Clin Biochem. 2016:1-9. doi:10.1007/s12291-016-0612-7.
  61. Nath P, Singh SP. Serum Transaminases: Quo Vadis. Biochem Anal Biochem 2016; 5: 260. doi.org/10.4172/2161-1009.1000260.
  62. Pati GK, Singh A, Nath P, Narayan J, Padhi PK, Parida PK, Pattnaik K, Panda C, Singh SP. A 10-year-old child presenting with syndromic paucity of bile ducts (Alagille syndrome): a case report. J Med Case Rep. 2016 Nov 30;10(1):342.
  63. Ramakrishna BS, Makharia GK, Ahuja V, Ghoshal UC, Jayanthi V, Perakath B, Abraham P, Bhasin DK, Bhatia SJ, Choudhuri G, Dadhich S, Desai D, Goswami BD, Issar SK, Jain AK, Kochhar R, Loganathan G, Misra SP, Ganesh Pai C, Pal S, Philip M, Pulimood A, Puri AS, Ray G, Singh SP, Sood A, Subramanian V; Indian Society of Gastroenterology Task Force on Inflammatory Bowel Diseases. Indian Society of Gastroenterology consensus statements on Crohn’s disease in India. Indian J Gastroenterol. 2015 Jan;34(1):3-22. doi: 10.1007/s12664-015-0539-6. Epub 2015 Mar 14.
  64. Duseja A, Singh SP, Saraswat VA, Acharya SK, Chawla YK, Chowdhury S, Dhiman RK, Jayakumar RV, Madan K, Misra SP, Mishra H, Modi SK, Muruganathan A, Saboo B, Sahay R, Upadhyay R. Non-alcoholic Fatty Liver Disease and Metabolic Syndrome-Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology. J Clin Exp Hepatol. 2015 Mar;5(1):51-68. doi: 10.1016/j.jceh.2015.02.006. Epub 2015 Mar 6.
  65. Sarkar N, Panigrahi R, Pal A, Biswas A, Singh SP, Kar SK, Bandopadhyay M, Das D, Saha D, Kanda T, Sugiyama M, Chakrabarti S, Banerjee A, Chakravarty R. Expression of microRNA-155 correlates positively with the expression of Toll-like receptor 7 and modulates hepatitis B virus via C/EBP-β in hepatocytes.J Viral Hepat. 2015 Feb 26. doi: 10.1111/jvh.12390.
  66. Kumar A, Acharya SK, Singh SP, Saraswat VA, Arora A, Duseja A, Goenka MK, Jain D, Kar P, Kumar M, Kumaran V, Mohandas KM, Panda D, Paul SB, Ramachandran J, Ramesh H, Rao PN, Shah SR, Sharma H, Thandassery RB; (The INASL Task-Force on Hepatocellular Carcinoma). The Indian National Association for Study of the Liver (INASL) Consensus on Prevention, Diagnosis and Management of Hepatocellular Carcinoma in India: The Puri Recommendations. J Clin Exp Hepatol. 2014 Aug;4(Suppl 3):S3-S26. doi: 10.1016/j.jceh.2014.04.003. Epub 2014 May 22.
  67. Dhiman RK, Saraswat VA, Valla DC, Chawla Y, Behera A, Varma V, Agarwal S, Duseja A, Puri P, Kalra N, Rameshbabu CS, Bhatia V, Sharma M, Kumar M, Gupta S, Taneja S, Kaman L, Zargar SA, Nundy S, Singh SP, Acharya SK, Dilawari JB. Portal cavernoma cholangiopathy: consensus statement of a working party of the Indian national association for study of the liver. J Clin Exp Hepatol. 2014 Feb;4(Suppl 1):S2-S14. doi: 10.1016/j.jceh.2014.02.003. Epub 2014 Feb 25. Review.
  68. Panigrahi R, Sarkar N, Biswas A, Pal A, Saha D, Singh SP, Panigrahi MK, Bandopadhyay M, Chakrabarti S, Chakravarty R. Association of TNF-α Promoter Polymorphism with HBV Associated Disease Outcome Among HBV Infected Patients from Orissa, Southern Part of East India. J Clin Exp Hepatol. 2014 Sep;4(3):202-8. doi: 10.1016/j.jceh.2014.08.002. Epub 2014 Sep 18.
  69. Puri P, Anand AC, Saraswat VA, Acharya SK, Sarin SK, Dhiman RK, Aggarwal R, Singh SP, Amarapurkar D, Arora A, Chhabra M, Chetri K, Choudhuri G, Dixit VK, Duseja A, Jain AK, Kapoor D, Kar P, Koshy A, Kumar A, Madan K, Misra SP, Prasad MV, Nagral A, Puri AS, Jeyamani R, Saigal S, Shah S, Sharma PK, Sood A, Thareja S, Wadhawan M. Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part II: INASL Recommendations for Management of HCV in India. J Clin Exp Hepatol. 2014 Jun;4(2):117-40. doi: 10.1016/j.jceh.2014.06.001. Epub 2014 Jun 24.
  70. Puri P, Anand AC, Saraswat VA, Acharya SK, Dhiman RK, Aggarwal R, Singh SP, Amarapurkar D, Arora A, Chhabra M, Chetri K, Choudhuri G, Dixit VK, Duseja A, Jain AK, Kapoorz D, Kar P, Koshy A, Kumar A, Madan K, Misra SP, Prasad MV, Nagral A, Puri AS, Jeyamani R, Saigal S, Sarin SK, Shah S, Sharma PK, Sood A, Thareja S, Wadhawan M. Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part I: Status Report of HCV Infection in India. J Clin Exp Hepatol. 2014 Jun;4(2):106-16. doi: 10.1016/j.jceh.2014.05.006. Epub 2014 Jun 9.
  71. Shenoy KT, Balakumaran LK, Mathew P, Prasad M, Prabhakar B, Sood A, Singh SP, Rao NP, Zargar SA, Bignamini AA. Metadoxine Versus Placebo for the Treatment of Non-alcoholic Steatohepatitis: A Randomized Controlled Trial. J Clin Exp Hepatol. 2014 Jun;4(2):94-100. doi: 10.1016/j.jceh.2014.03.041. Epub 2014 Mar 27.
  72. Dwibedi B, Sabat J, Ho LM, Singh SP, Sahu P, Arora R, Kar SK. Molecular epidemiology of hepatitis B virus in primitive tribes of Odisha, eastern India. Pathog Glob Health. 2014 Dec;108(8):362-8. doi: 10.1179/2047773214Y.0000000165. Epub 2014 Dec 16.
  73. Singh SP, Misra B, Kar SK, Panigrahi MK, Misra D, Bhuyan P, Pattnaik K, Meher C, Agrawal O, Rout N, Swain M. Nonalcoholic fatty liver disease (NAFLD) without insulin resistance: Is it different? Clin Res Hepatol Gastroenterol. 2014 Dec 17. pii: S2210-7401(14)00285-X. doi: 10.1016/j.clinre.2014.08.014. [Epub ahead of print]
  74. Bandopadhyay M, Banerjee A, Sarkar N, Panigrahi R, Datta S, Pal A, Singh SP, Biswas A, Chakrabarti S, Chakravarty R. Tumor suppressor micro RNA miR-145 and onco micro RNAs miR-21 and miR-222 expressions are differentially modulated by hepatitis B virus X protein in malignant hepatocytes. BMC Cancer. 2014 Sep 26;14:721. doi: 10.1186/1471-2407-14-721.
  75. Singh SP, Misra D, Panigrahi MK, Kar IB, Meher C. Corrosive esophageal injury due to elemental sodium ingestion. Trop Gastroenterol. 2014 Jan-Mar;35(1):44-5. No abstract available.
  76. Ghoshal UC, Abraham P, Bhatia SJ, Misra SP, Choudhuri G, Biswas KD, Chakravartty K, Dadhich S, Goswami BD, Jayanthi V, Kumar S, Koshy A, Kumar KR, Makharia G, Nijhawan S, Pratap N, Ray G, Sachdeva S, Singh SP, Thomas V, Udawat H. Comparison of Manning, Rome I, II, and III, and Asian diagnostic criteria: report of the Multicentric Indian Irritable Bowel Syndrome (MIIBS) study. Indian J Gastroenterol. 2013 Nov;32(6):369-75. doi: 10.1007/s12664-013-0365-7. Epub 2013 Sep 3.
  77. Singh SP, Kar SK, Panigrahi MK, Misra B, Pattnaik K, Bhuyan P, Meher C, Agrawal O, Rout N, Swain M. Profile of patients with incidentally detected nonalcoholic fatty liver disease (IDNAFLD) in coastal eastern India. Trop Gastroenterol. 2013 Jul-Sep;34(3):144-52.
  78. Singh SP, Panigrahi MK. Spectrum of upper gastrointestinal hemorrhage in coastal Odisha. Trop Gastroenterol. 2013 Jan-Mar;34(1):14-7.
  79. Singh SP, Panigrahi MK, Misra D, Misra B, Kaar SK, Panda CR, das HS, Agrawal O, Meher C. Barium emesis during barium enema study: a definitive sign of gastrojejunocolic fistula. Trop Gastroenterol. 2013 Oct-Dec;34(4):273-4. No abstract available.
  80. Panigrahi MK, Kar SK, Singh SP, Ghoshal UC. Defecation frequency and stool form in a coastal eastern Indian population.J Neurogastroenterol Motil. 2013 Jul;19(3):374-80. doi: 10.5056/jnm.2013.19.3.374. Epub 2013 Jul 8.
  81. Das HS, Panda C, Padhi S, Singh SP. Endoscopic diagnosis of a case of malignant melanoma. Trop Gastroenterol. 2012 Oct-Dec;33(4):296-7.
  82. Panigrahi R, Biswas A, Banerjee A, Singh SP, Panigrahi MK, Roque-Afonso AM, Das HS, Mahapatra PK, Chakrabarti S, Chakravarty R. Subgenotype D5, BCP and MHR mutations in hepatic complications among hepatitis B virus infected patients from Orissa, India. Infect Genet Evol. 2012 Dec;12(8):1622-9. doi: 10.1016/j.meegid.2012.06.015. Epub 2012 Jul 20.
  83. Ramakrishna BS, Makharia GK, Abraham P, Ghoshal UC, Jayanthi V, Agarwal BK, Ahuja V, Bhasin DK, Bhatia SJ, Choudhuri G, Dadhich S, Desai DC, Dhali GK, Goswami BD, Issar SK, Jain AK, Kochhar R, Kumar A, Loganathan G, Misra SP, Pai CG, Pal S, Pulimood A, Puri AS, Ramesh GN, Ray G, Singh SP, Sood A, Tandan M; Indian Society of Gastroenterology Task Force on Inflammatory Bowel Diseases. Indian Society of Gastroenterology consensus on ulcerative colitis. Indian J Gastroenterol. 2012 Dec;31(6):307-23. doi: 10.1007/s12664-012-0259-0. Epub 2012 Oct 25.
  84. Makharia GK, Ramakrishna BS, Abraham P, Choudhuri G, Misra SP, Ahuja V, Bhatia SJ, Bhasin DK, Dadhich S, Dhali GK, Desai DC, Ghoshal UC, Goswami BD, Issar SK, Jain AK, Jayanthi V, Loganathan G, Pai CG, Puri AS, Rana SS, Ray G, Singh SP, Sood A; Indian Society of Gastroenterology Task Force on Inflammatory Bowel Disease. Survey of inflammatory bowel diseases in India. Indian J Gastroenterol. 2012 Dec;31(6):299-306. doi: 10.1007/s12664-012-0258-1. Epub 2012 Oct 17.
  85. Bhatia SJ, Reddy DN, Ghoshal UC, Jayanthi V, Abraham P, Choudhuri G, Broor SL, Ahuja V, Augustine P, Balakrishnan V, Bhasin DK, Bhat N, Chacko A, Dadhich S, Dhali GK, Dhawan PS, Dwivedi M, Goenka MK, Koshy A, Kumar A, Misra SP, Mukewar S, Raju EP, Shenoy KT, Singh SP, Sood A, Srinivasan R. Epidemiology and symptom profile of gastroesophageal reflux in the Indian population: report of the Indian Society of Gastroenterology Task Force. Indian J Gastroenterol. 2011 May;30(3):118-27. doi: 10.1007/s12664-011-0112-x. Epub 2011 Jul 27.